Jeanne‐Yvonne Borg

698 total citations
19 papers, 450 citations indexed

About

Jeanne‐Yvonne Borg is a scholar working on Hematology, Genetics and Internal Medicine. According to data from OpenAlex, Jeanne‐Yvonne Borg has authored 19 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 6 papers in Genetics and 6 papers in Internal Medicine. Recurrent topics in Jeanne‐Yvonne Borg's work include Blood Coagulation and Thrombosis Mechanisms (11 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Jeanne‐Yvonne Borg is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (11 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Jeanne‐Yvonne Borg collaborates with scholars based in France, United States and Switzerland. Jeanne‐Yvonne Borg's co-authors include Véronique Le Cam‐Duchez, H. Lévesque, Jenny Goudemand, Benoît Guillet, Virginie Barbay, Bérangère S. Joly, Claude Négrier, Jean-François Ménard, Joseph Emmerich and Martine Alhenc‐Gelas and has published in prestigious journals such as Blood, American Journal of Obstetrics and Gynecology and British Journal of Haematology.

In The Last Decade

Jeanne‐Yvonne Borg

19 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeanne‐Yvonne Borg France 13 318 108 80 74 52 19 450
Predrag Miljić Serbia 15 265 0.8× 66 0.6× 47 0.6× 134 1.8× 56 1.1× 57 510
Isabel Tirado Spain 12 389 1.2× 127 1.2× 55 0.7× 193 2.6× 18 0.3× 21 528
Jordi Fontcuberta Spain 6 311 1.0× 80 0.7× 48 0.6× 227 3.1× 19 0.4× 7 426
Huub P J Willems Netherlands 5 267 0.8× 154 1.4× 16 0.2× 85 1.1× 279 5.4× 7 529
Mae B. Hultin United States 12 392 1.2× 85 0.8× 125 1.6× 80 1.1× 10 0.2× 19 513
J.Y. Borg France 10 190 0.6× 29 0.3× 67 0.8× 49 0.7× 73 1.4× 29 298
M Samama France 9 253 0.8× 61 0.6× 88 1.1× 129 1.7× 24 0.5× 51 430
Machin United Kingdom 7 223 0.7× 79 0.7× 63 0.8× 46 0.6× 9 0.2× 8 359
Ann Cullinane United States 9 179 0.6× 153 1.4× 73 0.9× 65 0.9× 7 0.1× 18 428
Anne Lienhart France 16 817 2.6× 231 2.1× 34 0.4× 103 1.4× 8 0.2× 51 917

Countries citing papers authored by Jeanne‐Yvonne Borg

Since Specialization
Citations

This map shows the geographic impact of Jeanne‐Yvonne Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeanne‐Yvonne Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeanne‐Yvonne Borg more than expected).

Fields of papers citing papers by Jeanne‐Yvonne Borg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeanne‐Yvonne Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeanne‐Yvonne Borg. The network helps show where Jeanne‐Yvonne Borg may publish in the future.

Co-authorship network of co-authors of Jeanne‐Yvonne Borg

This figure shows the co-authorship network connecting the top 25 collaborators of Jeanne‐Yvonne Borg. A scholar is included among the top collaborators of Jeanne‐Yvonne Borg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeanne‐Yvonne Borg. Jeanne‐Yvonne Borg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Joly, Bérangère S., et al.. (2017). Thrombin generation test as a marker for high risk venous thrombosis pregnancies. Journal of Thrombosis and Thrombolysis. 45(1). 114–121. 12 indexed citations
2.
Meunier, Sandrine, Roseline d’Oiron, Hérvè Chambost, et al.. (2016). Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25). Thrombosis Research. 151. 17–22. 3 indexed citations
3.
Bauduer, Frédéric, Emmanuelle de Raucourt, Catherine Boyer‐Neumann, et al.. (2015). Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3‐year postmarketing study. Haemophilia. 21(4). 481–489. 27 indexed citations
4.
5.
Benhamou, Y., Jérémy Bellien, G. Armengol, et al.. (2014). Role of Toll‐like Receptors 2 and 4 in Mediating Endothelial Dysfunction and Arterial Remodeling in Primary Arterial Antiphospholipid Syndrome. Arthritis & Rheumatology. 66(11). 3210–3220. 46 indexed citations
6.
Joly, Bérangère S., Virginie Barbay, Jeanne‐Yvonne Borg, & Véronique Le Cam‐Duchez. (2013). Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies. Thrombosis Research. 132(3). 386–391. 39 indexed citations
7.
Borg, Jeanne‐Yvonne, et al.. (2013). Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registry. Haemophilia. 19(4). 564–570. 114 indexed citations
8.
Benhamou, Y., Véronique Le Cam‐Duchez, N. Cailleux, et al.. (2009). Expérience d’un centre de suivi et de conseil des traitements anticoagulants oraux en médecine de ville : résultats à cinq ans. La Revue de Médecine Interne. 30(7). 567–572. 13 indexed citations
9.
Verspyck, Éric, et al.. (2009). Hereditary thrombophilia and recurrence of ischemic placental disease. American Journal of Obstetrics and Gynecology. 202(1). 54.e1–54.e5. 1 indexed citations
10.
Négrier, Claude, C. Rothschild, Jenny Goudemand, et al.. (2008). Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrate. Journal of Thrombosis and Haemostasis. 6(9). 1494–1499. 30 indexed citations
11.
Marie, I., Jeanne‐Yvonne Borg, M.-F. Hellot, & H. Lévesque. (2007). Plasma D-dimer concentration in patients with systemic sclerosis. British Journal of Dermatology. 0(0). 3154251836–???. 10 indexed citations
12.
Cam‐Duchez, Véronique Le, et al.. (2006). Factor V Cambridge mutation and activated protein C resistance assays. Thrombosis and Haemostasis. 95(3). 581–583. 3 indexed citations
13.
Cam‐Duchez, Véronique Le, et al.. (2005). Association of the protein C promoter CG haplotype and the factor II G20210A mutation is a risk factor for cerebral venous thrombosis. Blood Coagulation & Fibrinolysis. 16(7). 495–500. 14 indexed citations
14.
Neerman‐Arbez, Marguerite, Philippe de Moerloose, Christine A. Biron, et al.. (2001). Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes. Human Genetics. 108(3). 237–240. 56 indexed citations
15.
Cam‐Duchez, Véronique Le, Sophie Gandrille, David‐Alexandre Trégouët, et al.. (1999). Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutation. British Journal of Haematology. 106(4). 889–897. 12 indexed citations
16.
Alhenc‐Gelas, Martine, Véronique Le Cam‐Duchez, Joseph Emmerich, et al.. (1997). The A20210 Allele of the Prothrombin Gene Is Not Frequently Associated With the Factor V Arg 506 to Gln Mutation in Thrombophilic Families. Blood. 90(4). 1711–1711. 27 indexed citations
17.
Guédon, C, et al.. (1996). [Portal thrombosis disclosing antiphospholipid syndrome. 2 cases].. PubMed. 20(10). 897–900. 2 indexed citations
18.
Dérumeaux, Geneviève, Jeanne‐Yvonne Borg, O. Mejjad, et al.. (1995). Catastrophic antiphospholipid syndrome with fatal acute course in rheumatoid arthritis.. PubMed. 22(8). 1586–8. 12 indexed citations
19.
Borg, Jeanne‐Yvonne, Marc Vasse, & M. Monconduit. (1987). PROTEIN C : ROUEN - A NEW HEREDITARY PROTEIN C ABNORMALITY WITH LOW ANTICOAGULANT BUT NORMAL AMIDOLYTIC ACTIVITIES. Thrombosis and Haemostasis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Predrag Miljić Breakdown of academic impact, for papers by Isabel Tirado Breakdown of academic impact, for papers by Jordi Fontcuberta Breakdown of academic impact, for papers by Huub P J Willems Breakdown of academic impact, for papers by Mae B. Hultin Breakdown of academic impact, for papers by J.Y. Borg Breakdown of academic impact, for papers by M Samama Breakdown of academic impact, for papers by Machin Breakdown of academic impact, for papers by Ann Cullinane Breakdown of academic impact, for papers by Anne Lienhart
Rankless by CCL
2026